A detailed history of Martin Investment Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Martin Investment Management, LLC holds 284,204 shares of AZN stock, worth $18.3 Million. This represents 5.43% of its overall portfolio holdings.

Number of Shares
284,204
Previous 276,589 2.75%
Holding current value
$18.3 Million
Previous $21.6 Million 2.66%
% of portfolio
5.43%
Previous 5.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$76.67 - $87.62 $583,842 - $667,226
7,615 Added 2.75%
284,204 $22.1 Million
Q2 2024

Aug 05, 2024

BUY
$66.81 - $80.83 $18.5 Million - $22.4 Million
276,589 New
276,589 $21.6 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Martin Investment Management, LLC Portfolio

Follow Martin Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Martin Investment Management, LLC with notifications on news.